Targeting Vascular Endothelial Growth Factor: A Promising Strategy for Treating Age-Related Macular Degeneration

Author： Waisbourd Michael Loewenstein Anat Goldstein Michaella Leibovitch Igal

ISSN： 1170-229X

Source： Drugs & Aging, Vol.24, Iss.8, 2007-01, pp. : 643-662

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Dietary n-3 PUFA Vascular Targeting and the Prevention of Tumor Growth and Age-Related Macular Degeneration

Current Medicinal Chemistry, Vol. 16, Iss. 34, 2009-12 ,pp. : 4511-4526

Bentham Science Publishers

Access to resources Recommend Favorite

The Burden of Age-Related Macular Degeneration

By Schmier Jordana K. Jones Mechelle L. Halpern Michael T.

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 319-334

Adis International

Access to resources Recommend Favorite

Pegaptanib: In Exudative Age-Related Macular Degeneration

By Siddiqui M. Asif A. Keating Gillian M.

Drugs, Vol. 65, Iss. 11, 2005-01 ,pp. : 1571-1577

Adis International

Access to resources Recommend Favorite

By Lacour M.

Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. : 101-133

Adis International

Access to resources Recommend Favorite

Prospective therapeutics for age-related macular degeneration

By Chiesa R.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 527-541

Informa Healthcare

Access to resources Recommend Favorite